Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binghao Li

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cell Reports|December 3, 2023
Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaWenkan Zhang, Hao Zhou, Hengyuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional ChondrosarcomaBinghao Li, Guoqi Li, Xiaobo Yan, et al.
International Journal of Surgery (London, England)|April 22, 2022
Can "domino" therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapyHaochen Mou, Hao Qu, Binghao Li, et al.
Cell Reports|September 27, 2023
Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaWenkan Zhang, Hao Zhou, Hengyuan Li, et al.
Biomaterials|January 26, 2026
Spatiotemporal controls of neutrophil extracellular traps boosts neutrophils immunotherapy efficiency against solid tumorsLingxiao Jin, Liang Chen, Yucheng Xue, et al.
Cancer Immunology Research|March 8, 2018
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral ImmunosuppressionBinghao Li, Yang Zeng, Patrick M Reeves, et al.
Science Advances|January 17, 2024
Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunityHao Zhou, Wenkan Zhang, Hengyuan Li, et al.
Journal for Immunotherapy of Cancer|December 4, 2024
Natural lung-tropic T<sub>H</sub>9 cells: a sharp weapon for established lung metastasesTao Chen, Chenxiao Qiao, Eloy Yinwang, et al.
Cancer Research|May 9, 2018
Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In OsteosarcomaBinghao Li, Zhan Wang, Hao Wu, et al.
Bioactive Materials|December 14, 2022
Enhancement of T cell infiltration <i>via</i> tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumorsTao Chen, Yucheng Xue, Shengdong Wang, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cell Reports|December 3, 2023
Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaWenkan Zhang, Hao Zhou, Hengyuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional ChondrosarcomaBinghao Li, Guoqi Li, Xiaobo Yan, et al.
International Journal of Surgery (London, England)|April 22, 2022
Can "domino" therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapyHaochen Mou, Hao Qu, Binghao Li, et al.
Cell Reports|September 27, 2023
Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaWenkan Zhang, Hao Zhou, Hengyuan Li, et al.
Biomaterials|January 26, 2026
Spatiotemporal controls of neutrophil extracellular traps boosts neutrophils immunotherapy efficiency against solid tumorsLingxiao Jin, Liang Chen, Yucheng Xue, et al.
Cancer Immunology Research|March 8, 2018
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral ImmunosuppressionBinghao Li, Yang Zeng, Patrick M Reeves, et al.
Science Advances|January 17, 2024
Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunityHao Zhou, Wenkan Zhang, Hengyuan Li, et al.
Journal for Immunotherapy of Cancer|December 4, 2024
Natural lung-tropic T<sub>H</sub>9 cells: a sharp weapon for established lung metastasesTao Chen, Chenxiao Qiao, Eloy Yinwang, et al.
Cancer Research|May 9, 2018
Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In OsteosarcomaBinghao Li, Zhan Wang, Hao Wu, et al.
Bioactive Materials|December 14, 2022
Enhancement of T cell infiltration <i>via</i> tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumorsTao Chen, Yucheng Xue, Shengdong Wang, et al.
Pageof 7